FindTrial
Sign In

Usefulness of homoeopathic medicine in PCOS

Clinical Utility of Murphy Repertory in the selection of medicine for Polycystic Ovarian Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/026180
Enrollment
30
Registered
2020-06-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Homoeopathic Medicine: It shall be prescribed in varying potency and repetition will be done as per need of the patient for a minimum of 3 months Control Intervention1: not applicable:

Sponsors

Neha Sharma
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Unmarried and Married females with USG findings and Clinical evidence of Hirsutism Patient willing to participate in study with written consent form and having BMI 23 and above

Exclusion criteria

Exclusion criteria: patients not willing to sign consent form or are undergoing treatment for any other disease patient requiring emergency treatment

Design outcomes

Primary

MeasureTime frame
to assess the utility of murphy repertory in selection of medicine for PCOSTimepoint: 6 months—

Secondary

MeasureTime frame
To assess the effect of homoeopathic medicine on hormonal levels and usg findingsTimepoint: 18 months—

Countries

India

Contacts

Public ContactNeha Sharma

National Homoeopathic Medical College and hospital

drvishwajeetgupta@yahoo.com7000161425

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026